Skip to content

A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population

A Pilot Study To Assess The Dynamic Difficulty Adjustment In Personalized Testing For Persons With MCI And Matched Healthy Controls

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07174869
Acronym
ADAPT-MCI-01
Enrollment
32
Registered
2025-09-16
Start date
2025-09-19
Completion date
2026-07-09
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Alzheimer Disease, Mild Cognitive Impairment (MCI)

Brief summary

The goal of this observational study is to evaluate the functionality and usability of Indivi mobile application-based cognitive activities in people with mild cognitive impairment/mild Alzheimer's disease (PwMCI/AD) and healthy controls (HC). This application uses a dynamic difficulty adjustment (DDA) system that customizes the level of the cognitive activities to each user. The main questions it aims to answer are: * Does the DDA system reach a stable difficulty level at the same rate for both PwMCI/AD and HC? * Is the stable difficulty level reached by the DDA system different for PwMCI/AD compared to HC? Researchers will also compare cognitive activities results and other aspects of the mobile application's performance to see if the application can validly distinguish between the two groups. Participants will use the Indivi mobile application, with its embedded DDA system, for a 6-week period.

Interventions

None listed

Sponsors

Indivi AG
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Participant is part of BU-ADRC cohort. * Participant is diagnosed with MCI, mild AD, or is classified as HC per BU-ADRC, with available required data for inclusion obtained less than 2 years before the inclusion. * Participant is between 50 and 90 years old, included. * Participant is able to use a smartphone. * Participant has sufficient knowledge of the English language. * Participant is able to and has an intention to follow the study procedures. * Informed Consent as documented by signature.

Exclusion criteria

* Participant has any neurological condition that may be contributing to cognitive impairment (above and beyond that caused by the subject's MCI or AD). * Participant has psychiatric diagnosis or symptoms, (e.g., hallucinations, major depression, or delusions) that could interfere with study procedures. * Participant has a history of stroke or seizures within the last 24 months. * Participant has a Geriatric Depression Scale (GDS) score ≥8. * Participant has a severe visual or hearing impairment that would interfere with capacity to perform cognitive assessments. * Known or suspected non-compliance.

Design outcomes

Primary

MeasureTime frameDescription
Number of test iterations until stable difficulty level is reachedDuring the 6-week study period.Stable difficulty level is defined as no increase in difficulty across 3 consecutive test iterations. Comparison will be made between PwMCI and HC.
Distribution of participants across assessment levels at steady-state difficultyDuring the 6-week study periodSteady-state difficulty is defined as no increase in difficulty across 3 consecutive test iterations. The outcome will describe the distribution pattern of participants across the available assessment levels at steady-state.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026